Hyperlipidemia means you have higher-than-normal levels of fats (lipids) in your blood. These lipids include cholesterol and triglycerides, and when they stay elevated over time, they raise your risk of heart disease, stroke, and other serious problems. If you’ve seen this term on a lab report or heard it from your doctor, it’s essentially an umbrella diagnosis covering any combination of high LDL cholesterol, high triglycerides, high total cholesterol, or low HDL cholesterol.
What Counts as “High”
Hyperlipidemia is diagnosed through a blood test called a lipid panel. For adults 20 and older, healthy levels look like this:
- Total cholesterol: less than 200 mg/dL
- LDL (“bad”) cholesterol: less than 100 mg/dL
- HDL (“good”) cholesterol: 60 mg/dL or higher is ideal. Below 40 mg/dL for men or below 50 mg/dL for women is considered low.
- Triglycerides: below 150 mg/dL. Levels of 150 to 199 mg/dL are borderline high, and 200 mg/dL or above is high.
If any of these numbers fall outside the healthy range, you may be diagnosed with hyperlipidemia. The term itself doesn’t specify which lipid is the problem, so your doctor will point to the specific numbers that need attention.
Do You Need to Fast Before Testing?
You may have been told to fast for 9 to 12 hours before a lipid panel, but current guidelines from major cardiology organizations in the U.S., Europe, Canada, and the U.K. agree that a non-fasting blood draw is acceptable for most people. Non-fasting results predict cardiovascular risk just as well as fasting ones. Fasting may still be useful if your triglycerides come back above 400 mg/dL on a non-fasting test, or if you have a known genetic lipid disorder. People with diabetes should be especially aware that fasting for routine bloodwork can trigger low blood sugar episodes, with as many as 1 in 4 reporting a hypoglycemic event on the way to or from the lab.
Primary vs. Secondary Causes
Hyperlipidemia falls into two broad categories: primary (inherited) and secondary (acquired). Primary hyperlipidemia is genetic. You’re born with mutations that affect how your body processes cholesterol or triglycerides. Familial hypercholesterolemia is the most well-known form, causing dangerously high LDL levels from birth. Several other inherited conditions exist, each affecting a different step in lipid metabolism.
Secondary hyperlipidemia develops because of something else going on in your body or your life. Common drivers include an unhealthy diet, obesity, uncontrolled diabetes, hypothyroidism, kidney disease, and liver disease. Certain medications can also push your lipids up, including some blood pressure drugs, steroids, estrogen, immunosuppressants, anti-HIV medications, atypical antipsychotics, and retinoids used for skin conditions. Alcohol intake and smoking contribute as well. In many people, the cause is a combination of mild genetic susceptibility and lifestyle factors working together.
How High Lipids Damage Your Arteries
The main danger of hyperlipidemia is atherosclerosis, the slow buildup of plaque inside artery walls. This process starts when excess LDL particles slip through the inner lining of an artery and get trapped in the vessel wall. Once stuck there, these particles undergo chemical changes (particularly oxidation) that trigger an immune response. White blood cells rush in, swallow the modified cholesterol, and become bloated “foam cells.” This forms what’s called a fatty streak, the earliest visible sign of plaque.
Over years, smooth muscle cells migrate into the area and form a fibrous cap over the growing deposit. As long as that cap stays intact, blood flow may be only partially restricted. The real danger comes when the plaque becomes unstable: the core fills with dead cells and debris, the cap thins, and the plaque can rupture. A ruptured plaque triggers a blood clot that can block the artery entirely, causing a heart attack or stroke. This process typically unfolds over decades, which is why hyperlipidemia often causes no symptoms until a major event occurs.
Physical Signs You Might Notice
Most people with hyperlipidemia have no visible symptoms at all. But in severe cases, particularly inherited forms, cholesterol deposits can show up in the body. Xanthomas are yellowish, firm bumps that appear on the skin, often over the elbows, knees, or tendons in the hands and feet. Tendon xanthomas on the hands can sometimes be mistaken for arthritis-related joint changes. Corneal arcus, a grayish-white ring around the edge of the iris, is another sign of cholesterol deposition. In older adults, corneal arcus is common and not necessarily alarming, but in younger people it can point to a genetic lipid disorder.
When Triglycerides Get Dangerously High
While high LDL is most closely linked to heart disease, extremely high triglycerides carry their own acute risk: pancreatitis. This painful inflammation of the pancreas becomes a serious concern when triglyceride levels exceed 1,000 mg/dL. Among people with levels between 1,000 and 1,999 mg/dL, roughly 10% develop acute pancreatitis. At levels above 2,000 mg/dL, that figure rises to about 20%. This is a medical emergency, not a slow-developing condition like atherosclerosis.
How Hyperlipidemia Is Treated
Treatment depends on which lipids are elevated, how high they are, and your overall cardiovascular risk. For many people, the first step involves lifestyle changes: improving diet (less saturated fat, more fiber), increasing physical activity, losing excess weight, and quitting smoking. These measures can meaningfully shift your numbers, especially for triglycerides.
When lifestyle changes aren’t enough, medications come into play. Statins are the most widely prescribed option. They work by reducing your liver’s production of cholesterol, which forces liver cells to pull more LDL out of the bloodstream. This directly lowers the amount of LDL circulating in your arteries. For people who can’t tolerate statins or whose LDL remains too high despite them, newer injectable medications target a protein called PCSK9 that normally breaks down LDL receptors on liver cells. By blocking PCSK9, these drugs keep more receptors active, allowing the liver to clear LDL more efficiently. A newer option in this same category is given as an injection just twice a year, offering a less frequent dosing schedule.
For people with inherited forms of hyperlipidemia, treatment often needs to be more aggressive and may start in childhood. The specific approach depends on the genetic mutation involved and how severely it affects lipid levels.